Simpa Salami (@samsimsal) 's Twitter Profile
Simpa Salami

@samsimsal

Urologic Oncologist

ID: 322581779

calendar_today23-06-2011 12:12:30

340 Tweet

1,1K Followers

862 Following

Simpa Salami (@samsimsal) 's Twitter Profile Photo

⁦⁦⁦Cheryl Lee⁩ discussed intentional strategies to increase representation in clinical trials to ensure results are generalizable ⁦Society of Urologic Oncology⁩ / ⁦YUO⁩ symposium #SUO24

⁦⁦⁦<a href="/ctleeuro/">Cheryl Lee</a>⁩ discussed intentional strategies to increase representation in clinical trials to ensure results are generalizable ⁦<a href="/UroOnc/">Society of Urologic Oncology</a>⁩ / ⁦<a href="/SUO_YUO/">YUO</a>⁩ symposium #SUO24
YUO (@suo_yuo) 's Twitter Profile Photo

Congratulations to Udit Singhal, MD on winning the #YUO Paper of the Year Award for his nature publication “Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis” 👏👏👏

Congratulations to <a href="/theusinghal/">Udit Singhal, MD</a> on winning the #YUO Paper of the Year Award for his <a href="/Nature/">nature</a> publication “Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis” 👏👏👏
Michigan Urology (@umichurology) 's Twitter Profile Photo

Attention all medical students! The 2025 MUA application is now open for our virtual and in-person workshops. Scan QR code or visit michmed.org/NrDbG for more info. #Urology #medicalstudent #GoBlue #MUA2025

Attention all medical students! The 2025 MUA application is now open for our virtual and in-person workshops. Scan QR code or visit michmed.org/NrDbG for more info. #Urology #medicalstudent #GoBlue #MUA2025
Simpa Salami (@samsimsal) 's Twitter Profile Photo

Nice piece by Steven Monda and team in #ASCODailyNews: What Do Recent Clinical Trials Reveal About Biomarkers for Adjuvant Treatment in Localized RCC, and What’s Still Missing? dailynews.ascopubs.org/do/do-recent-c… ASCO Michigan Urology Udit Singhal, MD Todd 〽️ Morgan, MD

ASCO (@asco) 's Twitter Profile Photo

Among pts w localized RCC recurrence rates range from 40-50% after nephrectomy establishing a critical need for predictive #biomarkers. What do recent clinical trials reveal & what’s still missing? brnw.ch/21wPVdv #ASCODailyNews #kcsm Todd 〽️ Morgan, MD Udit Singhal, MD Simpa Salami

Among pts w localized RCC recurrence rates range from 40-50% after nephrectomy establishing a critical need for predictive #biomarkers. What do recent clinical trials reveal &amp; what’s still missing? brnw.ch/21wPVdv #ASCODailyNews #kcsm <a href="/wandering_gu/">Todd 〽️ Morgan, MD</a> <a href="/theusinghal/">Udit Singhal, MD</a> <a href="/samsimsal/">Simpa Salami</a>
Bárbara Melão, MD, PhD (@bavilima) 's Twitter Profile Photo

ASCO #GU25 Don’t forget to check out 2025 Daily News 👉 available at the entrance Andrea Apolo, M.D. Todd 〽️ Morgan, MD Simpa Salami ✨”… there is more to discuss than ever before” ✨Also, a great Editorial about biomarkers for adjuvant treatment in Localized RCC Michael Serzan, MD

<a href="/ASCO/">ASCO</a> #GU25 
Don’t forget to check out 2025 Daily News 👉 available at the entrance 
<a href="/apolo_andrea/">Andrea Apolo, M.D.</a> <a href="/wandering_gu/">Todd 〽️ Morgan, MD</a> <a href="/samsimsal/">Simpa Salami</a> 

✨”… there is more to discuss than ever before”
✨Also, a great Editorial about biomarkers for adjuvant treatment in Localized RCC

<a href="/MikeSerzanMD/">Michael Serzan, MD</a>
SIU-Urology (@siu_urology) 's Twitter Profile Photo

📣 Less Than One Month Left to Submit Your Abstract for #SIU2025Edinburgh! Don’t miss this opportunity to share your research on a global stage! Accepted abstracts will be: 📖 Published online as open access in the #SIUJ 🌍 Featured on #SIUAcademy as an ePoster Apply now

📣 Less Than One Month Left to Submit Your Abstract for #SIU2025Edinburgh!  

Don’t miss this opportunity to share your research on a global stage! Accepted abstracts will be: 
📖 Published online as open access in the #SIUJ 
🌍 Featured on #SIUAcademy as an ePoster  

Apply now
UroToday.com (@urotoday) 's Twitter Profile Photo

Spatial transcriptomic profiling to characterize the nature of peripheral- versus transition-zone #ProstateCancer. #AuthorCommentary Parth Patel, MD and Simpa Salami Michigan Urology discuss the biological and molecular distinctions between #PCa originating in the peripheral zone vs

Spatial transcriptomic profiling to characterize the nature of peripheral- versus transition-zone #ProstateCancer. #AuthorCommentary Parth Patel, MD and <a href="/samsimsal/">Simpa Salami</a> <a href="/UMichUrology/">Michigan Urology</a> discuss the biological and molecular distinctions between #PCa originating in the peripheral zone vs
UroToday.com (@urotoday) 's Twitter Profile Photo

Spatial transcriptomic profiling to characterize the nature of peripheral- versus transition-zone #ProstateCancer. #AuthorCommentary Parth Patel, MD and Simpa Salami Michigan Urology discuss the biological and molecular distinctions between #PCa originating in the peripheral zone vs

Spatial transcriptomic profiling to characterize the nature of peripheral- versus transition-zone #ProstateCancer. #AuthorCommentary Parth Patel, MD and <a href="/samsimsal/">Simpa Salami</a> <a href="/UMichUrology/">Michigan Urology</a> discuss the biological and molecular distinctions between #PCa originating in the peripheral zone vs
Simpa Salami (@samsimsal) 's Twitter Profile Photo

🚨 Early detection saves lives! Join us at #AUA2025 for the Prostate Cancer Early Detection Course — cutting-edge updates, expert-led discussions, and practical strategies you can bring back to clinic. Don’t miss it! 🔗 app.swapcard.com/event/2025-ann… #ProstateCancer #Urology

🚨 Early detection saves lives! Join us at #AUA2025 for the Prostate Cancer Early Detection Course — cutting-edge updates, expert-led discussions, and practical strategies you can bring back to clinic. Don’t miss it! 🔗 app.swapcard.com/event/2025-ann… #ProstateCancer #Urology
Jeff Tosoian, MD, MPH (@urooncjt) 's Twitter Profile Photo

HUGE step forward: no more DRE prior to urine sample. 18-marker test validated for at-home testing to rule out the need for MRI or biopsy. Great option for telehealth care. Big thanks to our multi-institutional team Todd 〽️ Morgan, MD Simpa Salami Ganesh Palapattu Daniel Barocas Ashley Ross MD PhD

HUGE step forward: no more DRE prior to urine sample. 18-marker test validated for at-home testing to rule out the need for MRI or biopsy. Great option for telehealth care. Big thanks to our multi-institutional team <a href="/wandering_gu/">Todd 〽️ Morgan, MD</a> <a href="/samsimsal/">Simpa Salami</a> <a href="/gpalapa2/">Ganesh Palapattu</a> <a href="/DanBarocas/">Daniel Barocas</a> <a href="/ashleyrossmdphd/">Ashley Ross MD PhD</a>
Todd 〽️ Morgan, MD (@wandering_gu) 's Twitter Profile Photo

What a thrill to host as VP former Michigan Urology UM Urology Residency Program resident and current Urology@UNC UNC Lineberger Director of Urologic Oncology Ray Tan. Amazing role model and tremendous thought leader in understanding physician-patient communication and decision-making. ⭐️ ⭐️

What a thrill to host as VP former <a href="/UMichUrology/">Michigan Urology</a> <a href="/UMUroResidency/">UM Urology Residency Program</a> resident and current <a href="/UNCurology/">Urology@UNC</a> <a href="/UNC_Lineberger/">UNC Lineberger</a> Director of Urologic Oncology <a href="/tanray22/">Ray Tan</a>. Amazing role model and tremendous thought leader in understanding physician-patient communication and decision-making. ⭐️ ⭐️
JCO Precision Oncology (@jcopo_asco) 's Twitter Profile Photo

Validation of a 15-Gene Prognostic Signature in Metastatic Clear Cell Renal Cell Carcinoma. Co-authored by Steven Monda. Read full article. brnw.ch/21wTiGs

Michigan Urology (@umichurology) 's Twitter Profile Photo

Welcome, Dr. Jason Qian! We're thrilled to announce our 2026 Society of Urologic Oncology (SUO) Fellow, who will be joining us from his residency at Massachusetts General Brigham. Welcome to Michigan Urology! 💙💛

Welcome, Dr. Jason Qian! We're thrilled to announce our 2026 Society of Urologic Oncology (SUO) Fellow, who will be joining us from his residency at Massachusetts General Brigham. Welcome to Michigan Urology! 💙💛